CIK 0001516551
- Non-accelerated filer
- Smaller reporting company
Skye Bioscience, Inc.
Sign in to watch- Ticker
- SKYE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 450692882
- Phone
- +1 858-410-0266
- Business address
- 11250 EL CAMINO REAL, SUITE 100, SAN DIEGO, CA, 92130
- Former names
- Emerald Bioscience, Inc., Nemus Bioscience, Inc., LOAD GUARD LOGISTICS, INC., LOAD GUARD TRANSPORTATION, INC.
- 4 Open-market sale Chief Development Officer sold 19,574 shares at an average $4.99 ($97,722)
- 4 Open-market sale Chief Financial Officer sold 43,396 shares at an average $4.99 ($216,652)
- 4 Open-market sale Chief Executive Officer sold 82,910 shares at an average $4.99 ($413,925)
- 4 Open-market sale Director sold 86,551 shares at an average $4.99 ($432,061)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 266,337 shares at an average $6.57 ($1,750,352)
- 4 Open-market sale 10% owner sold 266,337 shares at an average $6.57 ($1,750,352)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Other acquisition Chief Executive Officer acquired 15,727 shares (other)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 450,000 shares at $10.00 ($4,500,000)
Page 3 of 10 · 189 filings